Motor neuron disorders

Published on 19/03/2015 by admin

Filed under Pathology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2015 times

27

Motor neuron disorders

CLASSIFICATION

Diseases that affect motor neurons can be classified as either primary, secondary, or multisystem (Table 27.1). The terms ‘motor neuron diseases’ and ‘motor neuron disorders’ are used to refer to any disease affecting motor neurons. The specific term ‘motor neuron disease’ is used in Europe as a synonym for amyotrophic lateral sclerosis (ALS) and related disorders.

AMYOTROPHIC LATERAL SCLEROSIS (ALS)

NOMENCLATURE

ALS, progressive bulbar palsy (PBP), and progressive muscular atrophy (PMA) are generally considered to be variants of a single clinicopathologic syndrome. Primary lateral sclerosis (PLS) is regarded by many workers as a distinct entity because there is no involvement of lower motor neurons. These conditions (Table 27.2) are characterized as follows:

Clinical criteria for diagnosis divide cases into definite and probable ALS (Table 27.3). Since several diseases can be associated with motor neuron loss, secondary causes of motor neuron disease must be excluded.

Table 27.3

Revised World Federation of Neurology criteria for diagnosis of ALS

The diagnosis of ALS requires:

Four diagnostic categories are recognized:

1. Clinically definite ALS: on clinical grounds alone, evidence of UMN plus LMN signs in the bulbar region and in at least two spinal regions, or the presence of UMN signs in two spinal regions and LMN signs in three spinal regions

2. Clinically probable ALS: on clinical grounds alone, UMN plus LMN signs in at least 2 regions with some UMN signs rostral to LMN signs

3. Probable, laboratory supported ALS: this is defined, after proper application of neuroimaging and clinical laboratory protocols has excluded other causes, as:

4. Possible ALS is defined, once other diagnoses have been excluded, as:

The category of suspected ALS, previously included in the El Escorial criteria has been discarded

UMN, upper motor neuron; LMN, lower motor neuron; ALS, amyotrophic lateral sclerosis.

Typically, ALS progresses to death from respiratory failure or aspiration bronchopneumonia within 5 years of onset. Approximately 10–20% of patients develop disturbed frontal lobe cognition.

MICROSCOPIC APPEARANCES

The most characteristic finding is loss of motor neurons and astrocytosis in the spinal cord, brain stem, and motor cortex (Fig. 27.3). The remaining motor neurons in the spinal cord and brain stem may show cytoskeletal abnormalities.

image ETIOLOGY OF ALS

image GENETIC FORMS OF MOTOR NEURON DISEASE

A summary of the main genetic forms of MND is presented below.

Type of MND Linkage Gene
ALS1 AD adult 21q22 Cu/Zn SOD1 10–120% AD cases
ALS2 AR Juvenile 2q33 Alsin
ALS3 AD adult 18q21 Unknown – possibly commonest form of AD ALS
ALS4 AD Juvenile 9q34 SETX Senataxin
ALS5 AR Juvenile 15q15 SPG11 Spatacsin
ALS6 AD Adult 16p11.2 FUS Fused in sarcoma
ALS7 AD Adult 20p13 Unknown
ALS8 AD Adult 20q13.33 APB VAMP-associated protein B
ALS9 AD Adult 14q11 ANG Angiogenin
ALS10 AD Adult 1q36 TARDBP TAR DNA-binding protein
ALS11 AD Adult 6q21 FIG4 PI(3,5)P(2)5-phosphatase
ALS12 AR/AD Adult 10p15-p14 OPTN Optineurin
ALS 15 p11.23-p11.1 UBQLN2 gene
FTDALS 9p21 C9orf72 (GGGGCC)n expansion

AD, autosomal dominant; AR, autosomal recessive.

Inclusion bodies (Figs 27.427.8) may be seen in sections stained with hematoxylin and eosin (H&E) (Fig. 27.4), but the distinctive inclusions are more readily visualized by immunostaining for ubiquitin or P62 (Fig. 27.5). Inclusions are seen in both sporadic and familial ALS. In many patients with motor neuron disease there is aggregation and mislocation of the protein TDP-43. Normally located in the nucleus (Fig. 27.7) the protein accumulates in the cytoplasm and forms inclusions in disease (Fig. 27.8). More rarely, ALS of juvenile onset is associated with the formation of cytoplasmic aggregates of FUS (fused-in-sarcoma) protein, another protein normally located in the nucleus.

Motor neurons in the pons and medulla are often involved in the disease process and show histologic changes identical to those in the spinal anterior horn cells. The number of neurons in nuclei of the third, fourth, and sixth cranial nerves and Onufrowicz’s nuclei in the sacral cord is usually normal, but the cells may contain TDP-43-positive inclusions.

Loss of Betz cells may be evident in the motor cortex and be associated with astrocytic gliosis and microvacuolation (Fig. 27.9). Inclusions are not commonly found.

Degeneration of myelinated fibers in the corticospinal tracts (Figs 27.10, 27.11) is usually more marked distally in the spinal cord than proximally in the internal capsule and cerebral peduncles. There may also be a loss of myelinated fibers from the spinocerebellar tracts and posterior columns and some workers suggest that this is characteristic of familial cases. The degeneration of anterior horn cells results in a loss of nerve fibers from the anterior roots with associated endoneurial fibrosis (Fig. 27.12).

JUVENILE ALS WITH BASOPHILIC INCLUSIONS

An uncommon form of neurodegeneration, juvenile ALS with basophilic inclusion typically affects younger patients and leads to motor weakness. Inclusion bodies can be seen in motor neurons in H&E sections as well-defined basophilic structures (Fig. 27.14). It is recognized that these inclusions can be immunostained using antibodies to FUS (fused in sarcoma). Mutations in the gene coding for FUS have been found as a cause of this form of disease in some patients. This condition, presenting as juvenile ALS, is related to forms of frontotemporal lobar degeneration which are also characterized by FUS pathology in the group of FTLD-FUS discussed in Chapter 31. While mutations in the FUS gene have been found in ALS cases they are absent in FTLD-FUS.

X-LINKED BULBOSPINAL NEURONOPATHY (SPINOBULBAR MUSCULAR ATROPHY, KENNEDY’S DISEASE)

The disease is due to expansion of a tandem CAG repeat region in the first exon of the androgen receptor gene on the proximal part of the long arm of the X chromosome. Variable phenotypic expression between and within families is not clearly related to the size of the expansion.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

There is degeneration of facial, hypoglossal, and spinal cord motor neurons with neurogenic wasting of the corresponding skeletal muscles (particularly in the tongue). The third, fourth, and sixth cranial nerve nuclei are spared. Histologically, nuclear inclusions, detectable by immunostaining for the N-terminus of the AR protein or ubiquitin, can be found in affected spinal and brainstem motor neurons. Nuclear inclusions can also be found in non-neural tissues including skin, dermis, kidney, heart, and testis.

SPINAL MUSCULAR ATROPHY (SMA)

SMA is a disorder characterized by progressive lower motor neuron degeneration and four main features are used to subdivide SMA into different groups (Tables 27.4, 27.5).

Table 27.4

Features used to classify SMAs

Age of onset

Infantile

Juvenile

Adult

Distribution of weakness

Scapuloperoneal (proximal)

Distal

Complex

Severity and clinical progression

Acute (rapidly progressive to death)

Chronic (slowly progressive)

Pattern of inheritance

Autosomal recessive

Autosomal dominant

X-linked recessive

AUTOSOMAL RECESSIVE SMA

Three main clinical patterns of autosomal recessive SMA have been defined. All are caused by abnormalities in the same gene. They are:

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Most descriptions are of SMA1, very few are of SMA2 or 3. The skeletal muscles and anterior nerve roots appear macroscopically atrophic. Histology reveals a loss of motor neurons from the spinal cord, most obviously in the cervical and lumbar regions, and from the hypoglossal and other motor nuclei in the medulla and pons. Some of the remaining motor neurons may appear swollen (Fig. 27.15) and contain accumulations of abnormally phosphorylated neurofilaments. There is peripheral granular immunoreactivity for ubiquitin, but no distinct inclusions.

Connective tissue stains show that the anterior spinal nerve roots are relatively fibrotic. In some cases, there is obvious loss of anterior root axons. Loss of large myelinated axons may also be evident in peripheral nerves.

Skeletal muscle contains sheets of rounded atrophic fibers and scattered normal-sized or hypertrophic fibers (Fig. 27.16), often of histochemical type 1.

BULBOSPINAL MUSCULAR ATROPHY

Loss of neurons from the lower cranial nerve nuclei leading to progressive bulbar paresis occurs in two very uncommon inherited disorders that occur in childhood: Fazio–Londe disease and Brown–Vialetto–van Laere syndrome. An abnormality of the C20orf54 gene, which encodes the human homolog of a rat riboflavin transporter, has been implicated in both conditions.

HEREDITARY SPASTIC PARAPARESIS

Hereditary spastic paraparesis is a heterogeneous condition characterized by slowly progressive spastic paraparesis with autosomal dominant, autosomal recessive, and X-linked recessive types.

MACROSCOPIC AND MICROSCOPIC APPEARANCES

Neuropathologic examination shows predominantly distal degeneration of corticospinal and posterior column tracts (see Chapter 25 for the differential diagnosis of distal degeneration of long axons in the CNS). In some cases this is associated with a loss of Purkinje cells and degeneration of cerebellar dentate nuclei.

REFERENCES

Beghi, E., Balzarini, C., Bogliun, G., Italian ALS Study Group. Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis. Neuroepidemiology.. 2002;21(6):265–270.

Bosch, A.M., Abeling, N.G., Ijlst, L., et al. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. J Inherit Metab Dis.. 2011;34(1):159–164.

Bäumer, D., Hilton, D., Paine, S.M., et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology.. 2010;75(7):611–618.

Deng, H-X., Chen, W., Hong, S-T., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature.. 2011;477:211–215.

Finsterer, J. Perspectives of Kennedy’s disease. J Neurol Sci.. 2010;298(1–2):1–10.

Finsterer, J. Bulbar and spinal muscular atrophy (Kennedy’s disease): a review. Eur J Neurol.. 2009;16(5):556–561.

Geser, F., Stein, B., Partain, M., et al. Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy. Acta Neuropathol (Berl).. 2011;121(4):509–517.

Green, P., Wiseman, M., Crow, Y.J., et al. Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet.. 2010;86(3):485–489.

Grohmann, K., Varon, R., Stolz, P., et al. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol.. 2003;54(6):719–724.

Kaindl, A.M., Guenther, U.P., Rudnik-Schöneborn, S., et al. Spinal muscular atrophy with respiratory distress type 1 (SMARD1). J Child Neurol.. 2008;23(2):199–204.

Lagier-Tourenne, C., Cleveland, D.W. Rethinking ALS: the FUS about TDP-43. Cell.. 2009;136(6):1001–1004.

Logroscino, G., Traynor, B.J., Hardiman, O., EURALS. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry.. 2008;79(1):6–11.

Lorson, C.L., Rindt, H., Shababi, M. Spinal muscular atrophy: mechanisms and therapeutic strategies. Hum Mol Genet.. 2010;19(R1):R111–R118.

Mackenzie, I.R., Rademakers, R., Neumann, M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol.. 2010;9(10):995–1007.

Okita, T., Nodera, H., Shibuta, Y., et al. Can Awaji ALS criteria provide earlier diagnosis than the revised El Escorial criteria? J Neurol Sci.. 2011;302(1–2):29–32.

Renton, A.E., Majounie, E., Waite, A., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron.. 2011;72:257–268.

Rowland, L.P. Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve.. 2010;41(2):161–165.

Wee, C.D., Kong, L., Sumner, C.J. The genetics of spinal muscular atrophies. Curr Opin Neurol.. 2010;23(5):450–458.

Worms, P.M. The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci.. 2001;191(1–2):3–9.

Zoccolella, S., Beghi, E., Serlenga, L., et al. Classification of amyotrophic lateral sclerosis cases at presentation in epidemiological studies. Neurol Sci.. 2005;26(5):330–333.